Reading Time: 3 minutesIntroduction to Semaglutide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a promising therapeutic agent in the management of type 2 diabetes and obesity. Originally developed for adults, its application has been extended to adolescents, presenting both opportunities …